Sociedad Americana de Hirudoterapia

Lysozyme activity of the salivary gland secretion of the medicinal leech H. verbana, H. medicinalis and H. orientalis

Basic science published in Biomed Khim (2011)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyGenómica y proteómicaFarmacología salivalBaskova IP et al. · Biomeditsinskaia khimiia, 2011

Abstract

Salivary gland secretions of three species of the medicinal leech differ in the level of lysozyme peptidoglycan-lysing activity. Using the synthetic fluorogenic substrate, 4-methyl-umbelliferyl tetra N-acetyl-beta-chitotetraosid, the glycosidase activity (as one of peptidoglycan-lysing activities) of salivary gland secretion of three species of the medicinal leech was quantitatively evaluated in comparison with egg lysozyme. It is supposed, that lysozyme activity of the leech secretions is determined not only by 5 isoforms of destabilase-lysozyme, but by some other enzymes which can utilize this substrate. These may be lysozymes other than i- (invertebrate) lysozymes (such as destabilase-lysozyme, or related enzymes).

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal Article
Indexed MeSH termsAnimalsEndopeptidasesHirudo medicinalisIsoenzymesLeechesMuramidasePeptidoglycanSalivaSalivary GlandsSubstrate Specificity

Resumen

Three medicinal leech species differ in salivary lysozyme peptidoglycan-lysing activity.

Por qué esto importa para la hirudoterapia

This study quantitatively compared lysozyme peptidoglycan-lysing and glycosidase activities in salivary gland secretions of three species of the medicinal leech using a fluorogenic chitotetraoside substrate, finding interspecies differences and proposing that activity may reflect not only five isoforms of destabilase-lysozyme but also other, possibly non-i-type lysozymes. This is relevant to ASH's domain as a characterization of peptidoglycan-lysing components of leech salivary secretion across species. The caveat is that this is an in-vitro study of salivary gland secretion with no clinical data and no direct demonstration of therapeutic implications; interspecies differences may not translate to outcome differences in practice.

Citación

Lysozyme activity of the salivary gland secretion of the medicinal leech H. verbana, H. medicinalis and H. orientalis.

Baskova IP et al. · Biomeditsinskaia khimiia, 2011

DOI

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Species IdentificationTaxonomySalivary Gland SecretionAnti-Inflammatory MechanismsSalivary ComplexOtolaryngology

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.